Trial Search
Current Search Criteria:
Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 Diabetes
PHASE4This trial is conducted in Europe. The aim of this trial is to investigate ...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2004-03
Trial ID
NCT00600366
Treatments Being Tested
Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen™ in Subjects With Type 2 Diabetes
PHASE4This trial is conducted in Europe. The aim of this trial investigate the th...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2001-04-18
Trial ID
NCT01704378
Treatments Being Tested
Comparison of a Basal Plus One Insulin Regimen With a Biphasic Insulin Regimen in Type 2 Diabetes Patients
PHASE4The primary objective is to demonstrate the non-inferiority at six months o...
Status
Completed
Location
Investigational Site Number 204
Start Date
2009-07
Trial ID
NCT00965549
Treatments Being Tested
Comparison of Novo Rapid 30 Mix Injection FlexPen® and Humalog 25 Mix Injection KwikPen® in Type 2 Diabetic Patients
NAThe purpose of this study is to investigate patient's usability, preference...
Status
Unknown
Location
Nagaoka Red Cross Hospital
Start Date
2009-01
Trial ID
NCT00806975
Treatments Being Tested
Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 Diabetes
PHASE4This trial is conducted in Europe. The aim of this trial is to investigate ...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2002-08-19
Trial ID
NCT01467401
Treatments Being Tested
Mylan Insulin Aspart Study
PHASE3The aim of this phase III trial is to demonstrate the equivalence in the sa...
Status
Completed
Location
Endocrinology Associates Montgomery
Start Date
2018-11-07
Trial ID
NCT03760068
Treatments Being Tested
Post Marketing Surveillance Study of Biphasic Insulin Aspart 30
N/AThis study is conducted in Asia. The aim of this study is to review the saf...
Status
Completed
Location
Multiple Locations
Start Date
2004-09
Trial ID
NCT01536613
Treatments Being Tested
Investigating Bioequivalence Between Single-dose Liraglutide Administered Subcutaneously With Two Different Pen-injectors
PHASE1This trial is conducted in Europe. The aim of this trial is to investigate ...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2014-08
Trial ID
NCT02207348
Treatments Being Tested
Evaluating Safety of NovoPen® 3 and/or FlexPen® Devices in Routine Clinical Practice
N/AThis study is conducted in Asia. The aim of of this study is to evaluate th...
Status
Completed
Location
Multiple Locations
Start Date
2011-11
Trial ID
NCT01454024
Treatments Being Tested
Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 Diabetes
N/AThis study is conducted in Asia. The aim of this observational study is to ...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2007-02
Trial ID
NCT00715663
Treatments Being Tested